NovaBay Pharma (NBY) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $1.95 --0%
Financial Fact:
Total operating expenses: 4.89M
Today's EPS Names:
ELWT, CAAP, RNW, More
Financial Fact:
Total operating expenses: 4.89M
Today's EPS Names:
ELWT, CAAP, RNW, More
Join SI Premium – FREE
NovaBay Pharma (NYSE: NBY) reported Q2 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $1.01 million versus the consensus estimate of $610 thousand.
For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Infleqtion raises Q2 revenue to $13.5M after contract restatement
- PENN Entertainment (PENN) Reiterated at Market Outperform by Citizens as Relocation Announced
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
